
Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc.(NAUT)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · NAUT · 截至 2026年6月8日
活动摘要
买入笔数
5
P-Purchase only
卖出笔数
2
近12个月
买卖比
2.50
Buy/Sell (by trades)
整体情绪
Nautilus Biotechnology, Inc.内部人在过去近12个月净买入股份,可能反映对公司前景的信心。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
NAUT 季度内部人买卖趋势
NAUT 内幕交易卖出 · NAUT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · NAUT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
NAUT 高管卖出股份 · NAUT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 2, 2026 | AH Equity Partners Bio II, L.L.C. 10 percent owner | Sale | 4,615,974 | $10.85M⚡ | Form 4 |
| Jun 2, 2026 | AH Equity Partners Bio II, L.L.C. 10 percent owner | Sale | 384,026 | $902K | Form 4 |
| Mar 4, 2026 | Patel Sujal M CEO, President, and Secretary · Director | Purchase | 25,000 | $65K | Form 4 |
| Nov 6, 2025 | Suzuki Kentaro Chief Marketing Officer | Purchase | 4,000 | $6K | Form 4 |
| Sep 8, 2025 | Patel Sujal M CEO, President, and Secretary · Director | Purchase | 83,500 | $57K | Form 4 |
| Sep 5, 2025 | Patel Sujal M CEO, President, and Secretary · Director | Purchase | 116,500 | $79K | Form 4 |
| Sep 4, 2025 | Murphy Matthew B. General Counsel | Purchase | 20,000 | $13K | Form 4 |
| May 29, 2025 | Mowry Anna CFO and Treasurer | Purchase | 15,000 | $11K | Form 4 |
| May 12, 2025 | Mallick Parag Chief Scientist · Director | Purchase | 1,500 | $1K | Form 4 |
| May 8, 2025 | Mallick Parag Chief Scientist · Director | Purchase | 12,000 | $9K | Form 4 |
| Mar 20, 2025 | Patel Sujal M CEO, President, and Secretary · Director | Purchase | 23,933 | $24K | Form 4 |
| Mar 19, 2025 | Patel Sujal M CEO, President, and Secretary · Director | Purchase | 53,300 | $53K | Form 4 |
| Sep 23, 2024 | Godwin Mary E. Senior VP, Operations | Option | 47,031 | $22K | Form 4 |
| Sep 23, 2024 | Godwin Mary E. Senior VP, Operations | Sale | 47,031 | $135K | Form 4 |
| Sep 17, 2024 | Godwin Mary E. Senior VP, Operations | Option | 35,000 | $16K | Form 4 |
| Sep 17, 2024 | Godwin Mary E. Senior VP, Operations | Sale | 35,000 | $100K | Form 4 |
| Mar 11, 2024 | Patel Sujal M CEO, President, and Secretary · Director | Purchase | 12,044 | $34K | Form 4 |
| Mar 8, 2024 | Patel Sujal M CEO, President, and Secretary · Director | Purchase | 2,430 | $7K | Form 4 |
| Mar 7, 2024 | Patel Sujal M CEO, President, and Secretary · Director | Purchase | 18,854 | $54K | Form 4 |
| Mar 6, 2024 | Patel Sujal M CEO, President, and Secretary · Director | Purchase | 9,267 | $25K | Form 4 |
| Mar 5, 2024 | Patel Sujal M CEO, President, and Secretary · Director | Purchase | 7,405 | $20K | Form 4 |
| Sep 27, 2022 | Sankar Subramanian Senior VP, Product Development | Purchase | 5,000 | $10K | Form 4 |
| Sep 26, 2022 | Sankar Subramanian Senior VP, Product Development | Purchase | 10,000 | $20K | Form 4 |
| Sep 23, 2022 | Weld Gwen E CPO | Purchase | 30,000 | $61K | Form 4 |
| Sep 16, 2022 | Sankar Subramanian Senior VP, Product Development | Purchase | 35,000 | $75K | Form 4 |
AH Equity Partners Bio II, L.L.C.
10 percent owner
日期
Jun 2
股数
4,615,974
均价
$2.35
总金额
$10.85M ⚡
AH Equity Partners Bio II, L.L.C.
10 percent owner
日期
Jun 2
股数
384,026
均价
$2.35
总金额
$902K
Patel Sujal M
CEO, President, and Secretary · Director
日期
Mar 4
股数
25,000
均价
$2.61
总金额
$65K
Patel Sujal M
CEO, President, and Secretary · Director
日期
Sep 8
股数
83,500
均价
$0.68
总金额
$57K
Patel Sujal M
CEO, President, and Secretary · Director
日期
Sep 5
股数
116,500
均价
$0.67
总金额
$79K
Patel Sujal M
CEO, President, and Secretary · Director
日期
Mar 20
股数
23,933
均价
$1.00
总金额
$24K
Patel Sujal M
CEO, President, and Secretary · Director
日期
Mar 19
股数
53,300
均价
$0.99
总金额
$53K
Patel Sujal M
CEO, President, and Secretary · Director
日期
Mar 11
股数
12,044
均价
$2.84
总金额
$34K
Patel Sujal M
CEO, President, and Secretary · Director
日期
Mar 8
股数
2,430
均价
$2.99
总金额
$7K
Patel Sujal M
CEO, President, and Secretary · Director
日期
Mar 7
股数
18,854
均价
$2.89
总金额
$54K
Patel Sujal M
CEO, President, and Secretary · Director
日期
Mar 6
股数
9,267
均价
$2.70
总金额
$25K
Patel Sujal M
CEO, President, and Secretary · Director
日期
Mar 5
股数
7,405
均价
$2.65
总金额
$20K
Sankar Subramanian
Senior VP, Product Development
日期
Sep 27
股数
5,000
均价
$2.03
总金额
$10K
Sankar Subramanian
Senior VP, Product Development
日期
Sep 26
股数
10,000
均价
$2.02
总金额
$20K
Sankar Subramanian
Senior VP, Product Development
日期
Sep 16
股数
35,000
均价
$2.16
总金额
$75K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 NAUT 内幕交易
NAUT 内幕交易
Nautilus Biotechnology, Inc.(NAUT)内幕交易数据来源于公司内部人(包括Patel Sujal M (CEO, President, and Secretary · Director), AH Equity Partners Bio II, L.L.C. (10 percent owner), Suzuki Kentaro (Chief Marketing Officer))提交的SEC Form 4申报文件。过去12个月内,4位内部人向SEC提交了交易申报。NAUT内部人近期主要在买入,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Nautilus Biotechnology, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
NAUT 内幕交易 · 5个问题Nautilus Biotechnology, Inc.(NAUT)的内部人包括高管和董事,如Patel Sujal M (CEO, President, and Secretary · Director), AH Equity Partners Bio II, L.L.C. (10 percent owner), Suzuki Kentaro (Chief Marketing Officer)等。过去12个月内,4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026